36 computer-"https:"-"APOS-UFFICIO-CONCORSI-DOCENTI" "https:" "https:" "UCL" Fellowship positions
Sort by
Refine Your Search
-
Country
-
Employer
-
Field
-
audience. The ability to thrive in multi- and interdisciplinary research environments is a key requirement for this role. What we offer Visit https://www.ucl.ac.uk/work-at-ucl/rewards-and-benefits to find
-
Society until 31 May 2028 in the first instance with the possibility of extension. For a full job description please visit UCL’s online recruitment portal (https://www.ucl.ac.uk/work-at-ucl/search-ucl-jobs
-
Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. We will consider applications to work on a part-time, flexible, and job share basis wherever possible
-
neuroscience, cardiovascular neurophysiology, and neural computation. Researchers have access to state of the art facilities (https://www.ucl.ac.uk/science-technology-platforms/ ) and the department has close
-
maternity, paternity and adoption pay Employee assistance programme: Staff Support Service Discounted medical insurance Visit https://www.ucl.ac.uk/work-at-ucl/reward-and-benefits to find out more. We will
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
neuroscience, cardiovascular neurophysiology, and neural computation. Researchers have access to state of the art facilities (https://www.ucl.ac.uk/science-technology-platforms/) and the department has close
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and
-
About us The “Next-Gen Biopharma Manufacturing 5.0” Prosperity Partnership is a 5-year collaborative programme between UCL Biochemical Engineering and AstraZeneca, jointly funded by EPSRC and